George Clinical Applauded by Frost & Sullivan for Its Competitive Differentiation and Leadership in Strategy Execution in the Asia Pacific region

Avatar photo
Business Intelligence

George Clinical cares for its employees, enables business continuity, and builds on its expertise, giving it a competitive industry advantage.

SAN ANTONIO, May 4, 2023 /PRNewswire/ — Frost & Sullivan studied the contract research organization industry and, based on its findings, recognizes George Clinical with the 2023 Asia-Pacific Competitive Strategy Leadership Award. George Clinical is a global CRO with world class expertise in Kidney research, Oncology and Neurology and remains fully committed to growing their strong presence in Asia-Pacific which is where the company has its roots. It operates on the central tenet that its success depends on customer satisfaction, so it provides a human touch to its projects. A sustainable skilled workforce inherently ensures quality outcomes for clients and patients. High employee retention rates also result in new hires through current employee referrals and, more importantly, lower project downtime risks, reducing potential costs from replacing and training new hires.  Unlike larger contract research organizations (CROs), the company promotes a healthy work-life balance for its employees where they do not operate like machines when executing a trial.

George Clinical upholds its agility and responsiveness towards clients with nearly 500 employees, making it more flexible, adaptable, and faster than competitors with more employees. The company stands out in the industry as it works hard to deliver high-quality scientific services while identifying solutions for big biopharma. It meets with clients to assess their needs and develop tailored solutions with roadmaps for seamless execution, establishing ongoing trust with customers for long-lasting relationships. It links the science of an academic research organization (ARO) with a CRO’s global operational processes to meet standard operating procedures.

Azza Fazar, Frost & Sullivan best practices research analyst, observed, “George Clinical combines its connections with AROs and scientific expertise to find suitable sites and investigator networks, a unique competitive differentiator. The company facilitates faster patient-centric recruitment for its clients by bringing the best of both worlds.”

George Clinical works closely with customers during the pre- and post-purchase journey, offering support and guidance to achieve clinical trial excellence within specific therapeutic areas. It excels in creating brand awareness fueled by its exceptional operational strategies and customer-centric design, thus, achieving more leads. Its sterling reputation and customer-centric framework have led to its coveted preferred partner status. Additionally, it established a central monitoring team in India for cost-effectiveness, enabling it to monitor and prove the effectiveness of clinical trial trends across countries. With its long-standing GKPTN network access to a range of chronic kidney disease patients, client-focused oncology trial strategies and geographies, and best practice implementation, it outpaces competitors to lead the APAC CRO sector.

“George Clinical provides a human touch to its projects, ensuring quality outcomes for clients and patients. It develops and implements its growth strategies with customers in mind, solidifying its reputation in the sector,” noted Umesh Lal, Frost & Sullivan industry analyst. With its strong overall performance, George Clinical earns Frost & Sullivan’s 2023 APAC Competitive Leadership Award in the contract research organization industry.

Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that enhances current products and enables the development of new products and applications. The award recognizes the high sector acceptance potential of the recipient’s technology.

Frost & Sullivan Best Practices awards recognize companies in various regional and global sectors for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry experts compare sector participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Contact:
Tarini Singh
P: +91-9953764546
E: [email protected]

About George Clinical
George Clinical is a leading global clinical research organization founded in Asia-Pacific driven by scientific expertise and operational excellence. With over 20 years of experience and more than 450 people managing 39 geographical locations throughout the Asia-Pacific region, USA, and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration, and post-marketing trials.    
Website: https://www.georgeclinical.com 
LinkedIn: https://www.linkedin.com/company/george-clinical-pty-ltd 
Twitter: https://twitter.com/george_clinical 
Facebook: https://www.facebook.com/georgeclinical 
WeChat: https://mp.weixin.qq.com/.

For more information, contact:
Matthew Reabold
Head, US Business Development
T +1-760-645-0496
E [email protected] 
W georgeclinical.com | georgeinstitute.org

 

SOURCE Frost & Sullivan

相關文章

澳門行政長官賀一誠祝賀《澳門商業雜誌》成立二十周年

《澳門商業雜誌》和本集團Project Asia Corporation於本周五(5月24日)舉辦酒會,慶祝成立20周年。 澳門行政長官賀一誠致函《澳門商業雜誌》,對雜誌成立二十周年表示祝賀。

首季零售業銷售額按年減少12.5%

澳門統計暨普查局資料顯示,今年第1季零售業銷售額按年減少12.5%至207.1億澳門元,主要是因為去年首季經濟活動復常,消費需求集中釋放而形成高比較基數所致。

政府要求社團辦橫琴旅行團刺激澳門消費

當局敦促澳門社團利用特區政府最新推出的資助和電子消費券計劃,推廣橫琴旅遊,提振澳門城市經濟。

【總監之言】我們

引用Tomasi de Lampedusa的一句名言:為了有所改變,我們必須讓一切保持原狀。 

與新時代一同崛起

二十載風雨兼程,改變的不僅僅是澳門。我們改變了,世界也改變了。二十年前,澳門正沉醉於博彩市場開放初期帶來的興奮,這一決定最終成功將小城打造成世界頂尖的博彩中心,投注量及營運商和政府收入均領先行業。

行政長官:2023年博彩業佔本地生產總值36.2%

行政長官賀一誠週日表示,2023年博彩業佔本地生產總值(GDP)的36.2%,符合政府設定的經濟多元化目標。